Results for tag: "Prostatic Hyperplasia Device"

Prostatic Hyperplasia Device (PHD) is a medical device used to treat benign prostatic hyperplasia (BPH). BPH is a condition in which the prostate gland enlarges, causing urinary symptoms such as difficulty urinating, frequent urination, and a weak urine stream. PHD devices are minimally invasive and can be used to reduce the size of the prostate, improve urinary flow, and reduce symptoms. The devices are typically inserted through the urethra and use either laser energy, microwave energy, or radiofrequency energy to reduce the size of the prostate. The PHD device market is a rapidly growing segment of the medical device industry. It is expected to experience strong growth in the coming years due to the increasing prevalence of BPH and the growing demand for minimally invasive treatments. Some companies in the PHD device market include Boston Scientific, Medtronic, Urologix, and Lumenis. Show Less Read more